Consultative endocrinology:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Philadelphia [u.a.]
Saunders
2003
|
| Schriftenreihe: | Endocrinology and metabolism clinics of North America
32,2 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XIII S., S. 325 - 548 Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV017223736 | ||
| 003 | DE-604 | ||
| 005 | 20150123 | ||
| 007 | t | ||
| 008 | 030617s2003 ad|| |||| 00||| eng d | ||
| 035 | |a (OCoLC)52370749 | ||
| 035 | |a (DE-599)BVBBV017223736 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-19 |a DE-578 | ||
| 050 | 0 | |a RC648.A1 | |
| 084 | |a YC 3100 |0 (DE-625)153208: |2 rvk | ||
| 245 | 1 | 0 | |a Consultative endocrinology |c Henry B. Burch guest ed. |
| 264 | 1 | |a Philadelphia [u.a.] |b Saunders |c 2003 | |
| 300 | |a XIII S., S. 325 - 548 |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Endocrinology and metabolism clinics of North America |v 32,2 | |
| 650 | 7 | |a Advisering |2 gtt | |
| 650 | 7 | |a Endocrinologie |2 gtt | |
| 650 | 4 | |a Endocrine Diseases | |
| 650 | 4 | |a Endocrine Diseases |x complications | |
| 650 | 4 | |a Endocrine glands |x Diseases | |
| 650 | 4 | |a Endocrine glands |x Diseases |x Complications | |
| 650 | 4 | |a Endocrine manifestations of general diseases | |
| 650 | 4 | |a Postoperative Complications | |
| 650 | 4 | |a Surgery |x Complications | |
| 700 | 1 | |a Burch, Henry B. |e Sonstige |4 oth | |
| 830 | 0 | |a Endocrinology and metabolism clinics of North America |v 32,2 |w (DE-604)BV000625447 |9 32,2 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010380235&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-010380235 | ||
Datensatz im Suchindex
| _version_ | 1804130073484197888 |
|---|---|
| adam_text | CONSULTATIVE ENDOCRINOLOGY
CONTENTS
Preface xi
Henry B. Burch
Management of Surgically Hypogonadal Patients Unable
to Take Sex Hormone Replacement Therapy 325
Lynnette K. Nieman
After surgical castration, most men and women develop hot flashes
and osteoporosis and many women have symptoms of urogenital
atrophy. When patients cannot or do not wish to take gonadal ster¬
oids for the prevention or treatment of these problems, alternative
approaches can be offered. These include lifestyle modifications,
traditional medications and possibly some complementary and al¬
ternative approaches such as herbs, acupuncture or soy foods.
Timing and Special Concerns Regarding Endocrine
Surgery During Pregnancy 337
Susan Sam and Mark E. Molitch
This article focuses on the more common endocrinopathies that
occur during pregnancy and may require surgical treatment. The
optimal management of these disorders during pregnancy is
described with special emphasis regarding surgical treatment. Sur¬
gical indications, timing for surgery, and preoperative and post¬
operative management are discussed in detail.
Perioperative Management of Patients Undergoing
Pituitary Surgery 355
Mary Lee Vance
The management of a patient who requires pituitary surgery
should be a constant collaboration between the neurosurgeon and
the endocrinologist. Because the pituitary gland is an anatomic and
functional entity, both medical specialties are necessary to treat these
patients for the best possible outcome. The notion that pituitary
surgery is always curative is not accurate because of incom¬
plete tumor resection and the risk for tumor recurrence. A patient
with a pituitary lesion who undergoes surgery is clinically identical
to a patient with diabetes mellitus—these patients require lifelong
monitoring and management as indicated by the clinical, endocrine
and anatomic findings. Because there is always a risk for tumor re¬
currence, appropriate surgical or radiation treatment and hormone
replacement may be required at any time after the initial operation.
Perioperative Management of Patients Treated with
Glucocorticoids 367
Lloyd Axelrod
Hypothalamic pituitary adrenal (HPA) suppression is a common
consequence of glucocorticoid therapy. Overt secondary adrenal in¬
sufficiency from this treatment is a rare but life threatening condi¬
tion. This article addresses the following issues in patients
previously treated with glucocorticoids: the pathogenesis of hypo¬
tension, the incidence of perioperative adrenal insufficiency, the
time course of development of HPA suppression, the time course
of recovery from HPA suppression, management of HPA suppres¬
sion, preoperative assessment, and perioperative management. The
short adrenocorticotropic hormone test is the preferred study for
preoperative assessment of adrenocortical function. Recommenda¬
tions for perioperative glucocorticoid coverage of patients with
HPA suppression, with lower doses than in the past, now reflect
the normal physiologic response to surgical stress and consider
the duration and severity of the surgical procedure.
Endocrine Evaluation of Patients with Critical Illness 385
Greet Van den Berghe
The recent progress in knowledge of the neuroendocrine response
to critical illness and its interrelation with peripheral hormonal and
metabolic alterations during stress allows for potential new thera¬
peutic perspectives to safely reverse the wasting syndrome and im¬
prove survival.
Perioperative Management of Type 1 Diabetes Mellitus 411
Babette Carlson Glister and Robert A. Vigersky
With an estimated 1 million type 1 diabetes mellitus patients in the
United States today, approximately 50% of whom will require sur¬
gery of some kind during their lifetime, knowledge of their appro¬
priate perioperative management is extremely important. Whether
the surgery is being performed for a diabetic complication or an
unrelated condition, the presence of one or more of the complica¬
tions of diabetes increases the perioperative risk and prolongs hos
pitalization. A firm understanding of the pathophysiology of type
1 diabetes mellitus, the metabolic stress response, and the interac¬
tions between various forms of insulin and other variables such as
supplemental nutrition and glucocorticoids, can greatly assist in
achieving a positive outcome. The use of individually tailored IV
and subcutaneous insulin regimens is reviewed in this article with
the goal of maximizing glycemic control in an effort to reduce
costly in patient morbidity and mortality in this unique popula¬
tion.
Management of the Bariatric Surgery Patient 437
Derek J. Stacker
Morbid obesity has reached epidemic proportions in the United
States. Unfortunately, medical interventions have been largely inef¬
fective in this growing population. Currently, bariatric surgery is
the most effective intervention in managing morbid obesity and
its comorbidities. As more patients become eligible for and pursue
weight reduction surgery, it becomes important for the clinician to
possess a thorough understanding of the different procedures
available and the management of patients before, during, and after
these surgeries. Significant weight loss and improvement in
weight related comorbidities are possible, with the best results
available to the well informed patient whose care is provided by
a dedicated multidisciplinary team.
Evaluation and Management of Hypo Osmolality in
Hospitalized Patients 459
Natasa Janicic and Joseph G. Verbalis
Hyponatremia is the most common electrolyte disorder encoun¬
tered in the clinical setting. Abnormalities of the mechanisms that
maintain normal water and sodium metabolism are often present
in hospitalized patients, including defects in renal water excretion.
All of the current therapeutic approaches in patients with the syn¬
drome of inappropriate antidiuretic hormone secretion and other
forms of vasopressin induced hyponatremia have significant lim¬
itations. Studies in animal models and humans have demonstrated
that antagonists of the AVP V2 receptor in the kidney are effective
in correcting hyponatremia. These new agents have been termed
aquaretics because of their ability to induce a free water diuresis
without the natriuresis or kaliuresis characteristic of diuretic drugs.
When approved for clinical use, selective V2, and possibly also
combined VI + V2 receptor antagonists will be helpful in therapy.
Prevention, Evaluation, and Management of Complications
Following Thyroidectomy for Thyroid Carcinoma 483
Reza Zarnegar, Laurent Brunaud, and Orlo H. Clark
The rate of complications during thyroid surgery has decreased be¬
cause of better instrumentation, illumination, and surgical exper¬
tise. Despite these improvements, certain patients, including
those requiring reoperation, those with invasive cancers or with
numerous nodal metastasis or recurrent tumors, and those with
large substernal goiters have a low but appreciable risk for compli¬
cations. When planning a thyroid operation, one should perform
the operation that corrects these problems and decrease the risk
for complications. Localization of at least one parathyroid gland
is essential.
Perioperative Management of Patients with
Hypothyroidism 503
Nikolaos Stathatos and Leonard Wartofsky
Thyroid hormones have a wide variety of actions in virtually every
organ system. They play a crucial role in regulating important
functions such as cardiac contractility, vascular tone, water and
electrolyte balance, and normal function of the central nervous sys¬
tem. It is now widely accepted that euthyroid state marked by ade¬
quate levels of thyroid hormones is necessary to obtain the best
possible results from any kind of surgical intervention.
Perioperative Management of the Thyrotoxic Patient 519
Roy W. Langley and Henry B. Burch
Preoperative thyrotoxicosis is a potentially life threatening condi¬
tion that requires medical intervention before surgery. Most pa¬
tients are undergoing thyroidectomy for persistent thyrotoxicosis,
usually Graves disease, either having contraindications to or fail¬
ing medical therapy. Fewer patients are undergoing nonthyroidal
surgery that is likely urgent or emergent. The choice of treatment
depends on the time available for preoperative preparation, the se¬
verity of the thyrotoxicosis, and the impact of any current or pre¬
vious therapies. Generally, treatment is directed at a combination
of targets in the thyroid hormone synthetic, secretory, and periph¬
eral pathway with concurrent treatment to correct any decompen¬
sation of normal homeostatic mechanisms. Thionamides are the
preferred initial treatment unless contraindicated, but do require
several weeks to render a patient euthyroid. Beta adrenergic block
ers should be used unless absolutely contraindicated. Overall the
morbility and mortality of adequately prepared patients is low.
Index 533
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV017223736 |
| callnumber-first | R - Medicine |
| callnumber-label | RC648 |
| callnumber-raw | RC648.A1 |
| callnumber-search | RC648.A1 |
| callnumber-sort | RC 3648 A1 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | YC 3100 |
| ctrlnum | (OCoLC)52370749 (DE-599)BVBBV017223736 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01593nam a2200409 cb4500</leader><controlfield tag="001">BV017223736</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20150123 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">030617s2003 ad|| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)52370749</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV017223736</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC648.A1</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 3100</subfield><subfield code="0">(DE-625)153208:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Consultative endocrinology</subfield><subfield code="c">Henry B. Burch guest ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia [u.a.]</subfield><subfield code="b">Saunders</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIII S., S. 325 - 548</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Endocrinology and metabolism clinics of North America</subfield><subfield code="v">32,2</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Advisering</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Endocrinologie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrine Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrine Diseases</subfield><subfield code="x">complications</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrine glands</subfield><subfield code="x">Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrine glands</subfield><subfield code="x">Diseases</subfield><subfield code="x">Complications</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrine manifestations of general diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Postoperative Complications</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Surgery</subfield><subfield code="x">Complications</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burch, Henry B.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Endocrinology and metabolism clinics of North America</subfield><subfield code="v">32,2</subfield><subfield code="w">(DE-604)BV000625447</subfield><subfield code="9">32,2</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010380235&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-010380235</subfield></datafield></record></collection> |
| id | DE-604.BV017223736 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T19:15:14Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-010380235 |
| oclc_num | 52370749 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-578 |
| owner_facet | DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-578 |
| physical | XIII S., S. 325 - 548 Ill., graph. Darst. |
| publishDate | 2003 |
| publishDateSearch | 2003 |
| publishDateSort | 2003 |
| publisher | Saunders |
| record_format | marc |
| series | Endocrinology and metabolism clinics of North America |
| series2 | Endocrinology and metabolism clinics of North America |
| spelling | Consultative endocrinology Henry B. Burch guest ed. Philadelphia [u.a.] Saunders 2003 XIII S., S. 325 - 548 Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Endocrinology and metabolism clinics of North America 32,2 Advisering gtt Endocrinologie gtt Endocrine Diseases Endocrine Diseases complications Endocrine glands Diseases Endocrine glands Diseases Complications Endocrine manifestations of general diseases Postoperative Complications Surgery Complications Burch, Henry B. Sonstige oth Endocrinology and metabolism clinics of North America 32,2 (DE-604)BV000625447 32,2 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010380235&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Consultative endocrinology Endocrinology and metabolism clinics of North America Advisering gtt Endocrinologie gtt Endocrine Diseases Endocrine Diseases complications Endocrine glands Diseases Endocrine glands Diseases Complications Endocrine manifestations of general diseases Postoperative Complications Surgery Complications |
| title | Consultative endocrinology |
| title_auth | Consultative endocrinology |
| title_exact_search | Consultative endocrinology |
| title_full | Consultative endocrinology Henry B. Burch guest ed. |
| title_fullStr | Consultative endocrinology Henry B. Burch guest ed. |
| title_full_unstemmed | Consultative endocrinology Henry B. Burch guest ed. |
| title_short | Consultative endocrinology |
| title_sort | consultative endocrinology |
| topic | Advisering gtt Endocrinologie gtt Endocrine Diseases Endocrine Diseases complications Endocrine glands Diseases Endocrine glands Diseases Complications Endocrine manifestations of general diseases Postoperative Complications Surgery Complications |
| topic_facet | Advisering Endocrinologie Endocrine Diseases Endocrine Diseases complications Endocrine glands Diseases Endocrine glands Diseases Complications Endocrine manifestations of general diseases Postoperative Complications Surgery Complications |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010380235&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000625447 |
| work_keys_str_mv | AT burchhenryb consultativeendocrinology |